Changming Yu

3.0k total citations
51 papers, 641 citations indexed

About

Changming Yu is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Changming Yu has authored 51 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in Changming Yu's work include Viral Infections and Vectors (7 papers), Viral Infections and Outbreaks Research (7 papers) and Biochemical and Structural Characterization (7 papers). Changming Yu is often cited by papers focused on Viral Infections and Vectors (7 papers), Viral Infections and Outbreaks Research (7 papers) and Biochemical and Structural Characterization (7 papers). Changming Yu collaborates with scholars based in China, Czechia and Canada. Changming Yu's co-authors include Qingdong Zeng, Jianming Liu, Hongtao Liu, Shilin Liu, Ting Fang, Xiangyang Chi, Ling Fu, Rui Yu, Wei Chen and Jianmin Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Changming Yu

47 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changming Yu China 14 221 202 170 133 94 51 641
Michael B. Hall United Kingdom 12 285 1.3× 75 0.4× 6 0.0× 27 0.2× 12 0.1× 22 545
Huifeng Yu United States 12 124 0.6× 81 0.4× 4 0.0× 5 0.0× 285 3.0× 17 497
Chuyu Zhang China 12 139 0.6× 94 0.5× 2 0.0× 6 0.0× 77 0.8× 55 480
Mudan Zhang China 16 69 0.3× 189 0.9× 59 0.4× 164 1.7× 40 612
Niyaz Yoosuf Sweden 10 136 0.6× 81 0.4× 12 0.1× 53 0.6× 13 449
Natalie J. Griffiths United Kingdom 11 141 0.6× 54 0.3× 10 0.1× 128 1.4× 14 574
Rui Qi China 14 143 0.6× 273 1.4× 5 0.0× 1 0.0× 44 0.5× 47 537
Xiuchun Zhang China 15 224 1.0× 122 0.6× 8 0.1× 18 0.2× 53 1.1k
Mattias Mild Sweden 14 165 0.7× 312 1.5× 11 0.1× 70 0.7× 19 555

Countries citing papers authored by Changming Yu

Since Specialization
Citations

This map shows the geographic impact of Changming Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changming Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changming Yu more than expected).

Fields of papers citing papers by Changming Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changming Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changming Yu. The network helps show where Changming Yu may publish in the future.

Co-authorship network of co-authors of Changming Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Changming Yu. A scholar is included among the top collaborators of Changming Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changming Yu. Changming Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Yi, Pengfei Fan, Ting Fang, et al.. (2025). Potent Cross‐neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein. Advanced Science. 12(27). e2501996–e2501996. 1 indexed citations
2.
Li, Jie, Shaoyan Wang, Yue Cui, et al.. (2025). Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells. Virology Journal. 22(1). 275–275.
3.
Zhang, Huajun, Yanfeng Yao, Ming Li, et al.. (2024). Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains. Nature Communications. 15(1). 2987–2987. 13 indexed citations
4.
Fan, Pengfei, Bingjie Sun, Ting Fang, et al.. (2024). A pan-orthoebolavirus neutralizing antibody encoded by mRNA effectively prevents virus infection. Emerging Microbes & Infections. 13(1). 2432366–2432366.
5.
Zhang, Yuanyuan, Guanying Zhang, Ping Huang, et al.. (2024). A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2. Emerging Microbes & Infections. 13(1). 2373307–2373307. 3 indexed citations
6.
Chi, Xiangyang, Guanying Zhang, Ximin Chi, et al.. (2023). Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants. Cell Discovery. 9(1). 37–37. 6 indexed citations
7.
Hao, Meng, Zhendong Zhang, Yi Chen, et al.. (2023). A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques. npj Vaccines. 8(1). 164–164. 10 indexed citations
8.
Zeng, Weihong, Xiaoying Jia, Xiangyang Chi, et al.. (2023). An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variants. International Journal of Biological Macromolecules. 253(Pt 3). 126817–126817. 7 indexed citations
9.
Hao, Meng, Yi Chen, Ting Fang, et al.. (2023). An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice. Frontiers in Microbiology. 14. 1114226–1114226. 5 indexed citations
10.
11.
Wang, Busen, Meng Hao, Yi Chen, et al.. (2022). Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge. Frontiers in Immunology. 13. 907675–907675. 10 indexed citations
12.
Wang, Meirong, Ruihua Li, Yaohui Li, et al.. (2021). Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever. Viruses. 13(3). 484–484. 8 indexed citations
13.
Fan, Pengfei, Xiangyang Chi, Guodong Liu, et al.. (2020). Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors. mAbs. 12(1). 1742457–1742457. 17 indexed citations
14.
Yu, Rui, Shilin Liu, Ting Fang, et al.. (2017). Protection against Staphylococcus aureus and tetanus infections by a combined vaccine containing SasA and TeNT-Hc in mice. Molecular Medicine Reports. 15(4). 2369–2373. 6 indexed citations
15.
Chi, Xiangyang, Jianmin Li, Xiaolin Wang, et al.. (2015). Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine. Clinical and Vaccine Immunology. 22(5). 553–560. 10 indexed citations
16.
Dong, Lei, Xiaopeng Zhang, Jun Ren, et al.. (2013). Human Prostate Stem Cell Antigen and HSP70 Fusion Protein Vaccine Inhibits Prostate Stem Cell Antigen-Expressing Tumor Growth in Mice. Cancer Biotherapy and Radiopharmaceuticals. 28(5). 391–397. 5 indexed citations
17.
Ren, Jun, Jinlong Zhang, Jun Zhang, et al.. (2009). Protection against anthrax and plague by a combined vaccine in mice and rabbits. Vaccine. 27(52). 7436–7441. 10 indexed citations
18.
Zhang, Yanquan, Lifeng Fu, Changming Yu, et al.. (2005). siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication. Gene Therapy. 12(9). 751–761. 78 indexed citations
20.
Yu, Changming, et al.. (2000). Construction of human immunoglobulin combinatorial library and screening of phage antibodies to hepatitis A virus. Zhonghua weishengwuxue he mianyixue zazhi. 20(1). 49–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026